SG Americas Securities LLC raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 56.1% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 26,669 shares of the medical instruments supplier’s stock after buying an additional 9,580 shares during the period. SG Americas Securities LLC’s holdings in West Pharmaceutical Services were worth $2,521,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Burt Wealth Advisors boosted its stake in West Pharmaceutical Services by 38,540.0% in the first quarter. Burt Wealth Advisors now owns 1,932 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 1,927 shares during the period. Harfst & Associates Inc. acquired a new stake in West Pharmaceutical Services during the first quarter valued at approximately $186,000. Tyers Asset Management LLC boosted its stake in West Pharmaceutical Services by 17.6% in the first quarter. Tyers Asset Management LLC now owns 2,464 shares of the medical instruments supplier’s stock valued at $201,000 after buying an additional 368 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock valued at $210,000 after buying an additional 40 shares during the period. Finally, CIBC Asset Management Inc acquired a new stake in West Pharmaceutical Services during the second quarter valued at approximately $223,000. 90.51% of the stock is currently owned by institutional investors.

Shares of West Pharmaceutical Services, Inc. (WST) opened at 84.54 on Thursday. The stock has a market capitalization of $6.26 billion, a PE ratio of 36.28 and a beta of 1.10. West Pharmaceutical Services, Inc. has a 52-week low of $70.17 and a 52-week high of $99.91. The company’s 50 day moving average price is $89.81 and its 200 day moving average price is $88.88.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The business had revenue of $397.60 million for the quarter, compared to analysts’ expectations of $406 million. During the same quarter in the previous year, the firm earned $0.59 earnings per share. The business’s revenue was up 2.5% compared to the same quarter last year. On average, equities research analysts anticipate that West Pharmaceutical Services, Inc. will post $2.69 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be given a dividend of $0.14 per share. The ex-dividend date is Tuesday, October 17th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.66%. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. West Pharmaceutical Services’s payout ratio is 22.22%.

TRADEMARK VIOLATION NOTICE: This news story was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/24/west-pharmaceutical-services-inc-wst-position-raised-by-sg-americas-securities-llc.html.

Several equities research analysts recently commented on WST shares. BidaskClub cut West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Zacks Investment Research raised West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $108.00 price objective on the stock in a research report on Saturday, June 17th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $90.00 price objective on shares of West Pharmaceutical Services in a research report on Thursday, June 8th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $90.18.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.